Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | KDM6B | O15054 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 2/20 | 0.47 |
| ▸ | KDM5C | P41229 | 2/20 | 0.47 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.47 |
| ▸ | KDM3A | Q9Y4C1 | 2/20 | 0.47 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 10/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 10/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.45 |
| ▸ | ITGAV | P06756 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4097453 | 0.86 | ALDH1A1 (0.48) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL308968 | 0.81 | HSP90AA1 (0.43) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL17773820 | 0.77 | MAPT (0.55) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL17773816 | 0.77 | MAPT (0.55) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL17773807 | 0.77 | MAPT (0.55) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL17773812 | 0.77 | MAPT (0.55) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL17773829 | 0.77 | MAPT (0.55) | KDM4EKDM6BKDM4AKDM5CKDM4C | |
| SCHEMBL4398060 | 0.76 | ITGB3 (0.68) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL4717622 | 0.76 | ITGB3 (0.68) | HDAC1HDAC6HDAC3HDAC4HDAC7 | |
| SCHEMBL22691229 | 0.76 | CDC25A (0.43) | KDM4EHDAC1HDAC6HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10219730-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2019-03-05 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-9320467-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-9320467-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140364710-A1 | Redox Polymers | THERASENSE, INC. | 2014-12-11 | — | — | US | disclosed |
| US-20140364710-A1 | Redox Polymers | THERASENSE, INC. | 2014-12-11 | — | — | US | disclosed |
| US-8828204-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-8828204-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-8795490-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090145757-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2009-06-11 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | ABBOTT DIABETES CARE INC. | 2009-04-16 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-20070007132-A1 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. | 2007-01-11 | — | — | US | disclosed |
| US-7090756-B2 | Controller for redox system | THERASENSE INC. (US) | 2006-08-15 | — | — | US | disclosed |
| EP-1230249-B1 | TRANSITION METAL COMPLEXES WITH BIDENTATE LIGAND HAVING AN IMIDAZOLE RING | THERASENSE INC (US) | 2004-06-02 | — | — | EP | disclosed |
| US-20040040840-A1 | Controller for redox system | THERASENSE, INC. | 2004-03-04 | — | — | US | disclosed |
| US-6605201-B1 | Charge transfer compounds comprising osmium compounds coupled to polymers, used as biosensors | THERASENSE, INC. | 2003-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090099434-A1 | OXYGEN-EFFECT FREE ANALYTE SENSOR | LPO, TXN2, PRDX5 | KDM4E 1493/4885KDM6B 1705/4885KDM4A 1454/4885 |
| US-20040040840-A1 | Controller for redox system | OTC, ME3, PPOX | KDM4E 1472/4885KDM6B 2345/4885KDM4A 793/4885 |
| US-10219730-B2 | Redox polymers | PPOX, OTC, ME3 | KDM4E 2030/4885KDM6B 3155/4885KDM4A 1401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.